|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
63,610,000 |
Market
Cap: |
256.35(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$3.6 - $7.33 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 15.6 |
Insider 6 Months : 15.6 |
Insider 3/6 Months : 31.7 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile MeiraGTx Holdings is a clinical stage gene therapy company with six programs in clinical development and a pipeline of preclinical and research programs. Co.'s focus is on three areas of unmet medical need: ocular, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases and severe forms of xerostomia. Co.'s product candidates include: AAV-RPE65 for the treatment of retinal dystrophy associated with mutations in the RPE65 gene; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of Leber congenital amaurosis 4; as well as AAV-RDH12 for the treatment of RDH12 Mutation-Associated Retinal Dystrophy.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
1,250,000 |
1,250,000 |
1,250,000 |
5,597,826 |
Total Buy Value |
$5,000,000 |
$5,000,000 |
$5,000,000 |
$30,000,000 |
Total People Bought |
1 |
1 |
1 |
1 |
Total Buy Transactions |
1 |
1 |
1 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Naylor Stuart |
Chief Development Officer |
|
2021-04-29 |
4 |
AS |
$15.02 |
$21,103 |
D/D |
(1,405) |
432,840 |
|
- |
|
Naylor Stuart |
Chief Development Officer |
|
2021-04-28 |
4 |
AS |
$15.14 |
$57,108 |
D/D |
(3,772) |
434,245 |
|
- |
|
Marcus Joel S |
Director |
|
2021-03-15 |
4 |
OE |
$7.72 |
$99,449 |
D/D |
12,882 |
12,882 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2021-03-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
1,320,781 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2021-02-17 |
4 |
AS |
$15.57 |
$233,550 |
D/D |
(15,000) |
1,321,781 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2021-02-16 |
4 |
AS |
$15.60 |
$234,000 |
D/D |
(15,000) |
1,336,781 |
|
- |
|
Naylor Stuart |
Chief Development Officer |
|
2021-01-05 |
4 |
AS |
$15.34 |
$92,040 |
D/D |
(6,000) |
438,017 |
|
- |
|
Naylor Stuart |
Chief Development Officer |
|
2021-01-04 |
4 |
AS |
$15.40 |
$92,400 |
D/D |
(6,000) |
444,017 |
|
- |
|
Giroux Richard |
CFO & COO |
|
2020-12-17 |
4 |
AS |
$16.00 |
$288,000 |
D/D |
(18,000) |
846,518 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2020-12-17 |
4 |
AS |
$15.00 |
$200,850 |
D/D |
(13,390) |
1,355,781 |
|
- |
|
Edelman Joseph |
Director |
|
2020-11-23 |
4 |
B |
$12.85 |
$6,425,000 |
I/I |
500,000 |
6,933,277 |
2.1 |
- |
|
Forbes Alexandria |
President and CEO |
|
2020-11-18 |
4 |
AS |
$15.05 |
$24,231 |
D/D |
(1,610) |
1,369,171 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2020-11-17 |
4 |
AS |
$15.17 |
$227,550 |
D/D |
(15,000) |
1,370,781 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2020-11-12 |
4/A |
AS |
$15.01 |
$133,454 |
D/D |
(8,891) |
1,385,781 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2020-11-12 |
4 |
AS |
$15.01 |
$117,844 |
D/D |
(7,851) |
1,388,748 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2020-11-11 |
4/A |
AS |
$15.02 |
$40,524 |
D/D |
(2,698) |
1,394,672 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2020-11-11 |
4 |
AS |
$15.02 |
$37,520 |
D/D |
(2,498) |
1,396,599 |
|
- |
|
Naylor Stuart |
Chief Development Officer |
|
2020-11-10 |
4/A |
AS |
$15.00 |
$72,765 |
D/D |
(4,851) |
450,017 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2020-11-10 |
4/A |
AS |
$15.05 |
$217,172 |
D/D |
(14,430) |
1,397,370 |
|
- |
|
Naylor Stuart |
Chief Development Officer |
|
2020-11-10 |
4 |
AS |
$15.00 |
$56,085 |
D/D |
(3,739) |
451,129 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2020-11-10 |
4 |
AS |
$15.05 |
$191,180 |
D/D |
(12,703) |
1,399,097 |
|
- |
|
Naylor Stuart |
Chief Development Officer |
|
2020-11-09 |
4 |
AS |
$15.00 |
$7,680 |
D/D |
(512) |
454,868 |
|
- |
|
Forbes Alexandria |
President and CEO |
|
2020-11-05 |
4 |
AS |
$15.03 |
$59,834 |
D/D |
(3,981) |
1,411,800 |
|
- |
|
Naylor Stuart |
Chief Development Officer |
|
2020-11-05 |
4 |
AS |
$15.02 |
$124,396 |
D/D |
(8,282) |
455,380 |
|
- |
|
Naylor Stuart |
Chief Development Officer |
|
2020-10-05 |
4 |
AS |
$15.00 |
$4,515 |
D/D |
(301) |
463,662 |
|
- |
|
130 Records found
|
|
Page 4 of 6 |
|
|